AI Science Tracker
EN

School of Pharmacy, Beihua University, Jilin, Jilin, China

1 discovery from 2024

Discoveries

Evaluating the prognostic potential of telomerase signature in breast cancer through advanced machine learning model.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: ML-selected six-gene telomerase signature stratified breast-cancer survival across cohorts and linked high scores to genomic and cellular features.

Technology: ML signature and survival associations are evaluated across nine datasets and against 66 published signatures; independent cohorts support retrospective prognostic discrimination.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ML signature and survival associations are evaluated across nine datasets and against 66 published signatures; independent cohorts support retrospective prognostic discrimination.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1462953/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.